Positive Results from a Study of Patients with Diabetic Peripheral Neuropathy19 December,2016
A New Look at a Therapeutic Treatment for Diabetic Peripheral Neuropathy (DPN)
segments from the Press Release:
FlowAid Medical Technologies Corp. announced positive results from a study of the usage of its FA100 Sequential Contraction Compression Device among a group of patients with diabetic peripheral neuropathy. Following 30 days of supervised home use, the patients reported significantly less pain, less reliance on analgesics and fewer nights of disturbed sleep.
FlowAid CEO Jacob Brezel: “The new research could alter the way Diabetic Neuropathy is understood and treated. Use of the FA100 SCCD on patients suffering from hypoesthetic DPN restores sensation. We are planning larger studies that will bear out our findings”
Based on the study “Sequential Contraction Compression Device Therapy affects Symptomatic Diabetic Peripheral Neuropathy”, published in the Journal of Diabetic Complications & Medicine accessible on our Clinical webpage